[HTML][HTML] Advances in the management of diabetes mellitus: a focus on personalized medicine
FNU Sugandh, M Chandio, FNU Raveena, L Kumar… - Cureus, 2023 - ncbi.nlm.nih.gov
Diabetes mellitus poses a substantial global health challenge, necessitating innovative
approaches to improve patient outcomes. Conventional one-size-fits-all treatment strategies …
approaches to improve patient outcomes. Conventional one-size-fits-all treatment strategies …
Metabolic comorbidities in Cushing's syndrome
F Ferrau, M Korbonits - European Journal of Endocrinology, 2015 - academic.oup.com
Cushing's syndrome (CS) patients have increased mortality primarily due to cardiovascular
events induced by glucocorticoid (GC) excess-related severe metabolic changes. Glucose …
events induced by glucocorticoid (GC) excess-related severe metabolic changes. Glucose …
Cushing's syndrome: Overview of clinical presentation, diagnostic tools and complications
M Barbot, M Zilio, C Scaroni - … practice & research Clinical endocrinology & …, 2020 - Elsevier
Cushing's syndrome (CS) is a severe condition that results from chronic exposure to
elevated circulating cortisol levels; it is a rare but potentially life-threating condition …
elevated circulating cortisol levels; it is a rare but potentially life-threating condition …
Excess morbidity persists in patients with Cushing's disease during long-term remission: a Swedish nationwide study
E Papakokkinou, DS Olsson… - The Journal of …, 2020 - academic.oup.com
Context Whether multisystem morbidity in Cushing's disease (CD) remains elevated during
long-term remission is still undetermined. Objective To investigate comorbidities in patients …
long-term remission is still undetermined. Objective To investigate comorbidities in patients …
Cushing syndrome: diagnostic workup and imaging features, with clinical and pathologic correlation
NA Wagner-Bartak, A Baiomy… - American Journal of …, 2017 - Am Roentgen Ray Soc
OBJECTIVE. Cushing syndrome (CS) is a constellation of clinical signs and symptoms
resulting from chronic exposure to excess cortisol, either exogenous or endogenous …
resulting from chronic exposure to excess cortisol, either exogenous or endogenous …
Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study
Context: Somatic mutations in PRKACA gene, encoding the catalytic subunit of protein
kinase A (PKA), have been recently found in a high proportion of sporadic adenomas …
kinase A (PKA), have been recently found in a high proportion of sporadic adenomas …
Glucocorticoid hormones and energy homeostasis
RM de Guia, AJ Rose, S Herzig - Hormone molecular biology and …, 2014 - degruyter.com
Glucocorticoids (GC) and their cognate intracellular receptor, the glucocorticoid receptor
(GR), have been characterised as critical checkpoints in the endocrine control of energy …
(GR), have been characterised as critical checkpoints in the endocrine control of energy …
Concurrent hyperadrenocorticism and diabetes mellitus in dogs
DD Miceli, OP Pignataro, VA Castillo - Research in veterinary science, 2017 - Elsevier
Hyperadrenocorticism (HAC) and diabetes mellitus (DM) are two diseases that can occur
concurrently in dogs. The objective of this study was to evaluate the coexistence of HAC and …
concurrently in dogs. The objective of this study was to evaluate the coexistence of HAC and …
Hypothalamic–pituitary diseases and erectile dysfunction
Several hormones contribute to ensure penile erection, a neurovascular phenomenon in
which nitric oxide plays a major role. Erectile dysfunction (ED), which is defined as the …
which nitric oxide plays a major role. Erectile dysfunction (ED), which is defined as the …
PRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors
AS Berthon, E Szarek, CA Stratakis - Frontiers in cell and …, 2015 - frontiersin.org
Cyclic-AMP (cAMP)-dependent protein kinase (PKA) is the main effector of cAMP signaling
in all tissues. Inactivating mutations of the PRKAR1A gene, coding for the type 1A regulatory …
in all tissues. Inactivating mutations of the PRKAR1A gene, coding for the type 1A regulatory …